Gefitinib Iressa Just As Effective As Chemotherapy For Lung Cancer, According To Clinical Trial
Thursday, November 20, 2008 - 22:07
in Health & Medicine
Gefitinib, also known as Iressa, the once-promising targeted therapy for the treatment of non-small cell lung cancer, has proven as effective as chemotherapy as a second-line therapy for the disease with far fewer side effects, according to an international Phase III clinical trial, led by Advertisement: read more
Read the whole article on Scientific Blogging
More from Scientific Blogging
Related
- Iressa proves just as effective as chemotherapy for lung cancerThu, 20 Nov 2008, 19:32:03 EST
- Iressa shows promise for treatment of metastatic breast cancer when combined with hormonal therapyFri, 16 May 2008, 11:22:13 EDT
- Vandetanib shows clinical benefit when combined with docetaxel for lung cancerMon, 1 Jun 2009, 9:44:28 EDT
- Proton therapy may reduce serious side effect of lung cancer treatmentThu, 13 Nov 2008, 10:51:08 EST
- Study establishes role for gefitinib in Asian nonsmokers with lung cancerTue, 16 Sep 2008, 10:44:17 EDT